SOLIGENIX, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales AgreementSoligenix, Inc. • August 16th, 2024 • Pharmaceutical preparations • New York
Company FiledAugust 16th, 2024 Industry JurisdictionSoligenix, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with A.G.P./Alliance Global Partners (“AGP”) as follows: